| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
48,610 |
42,487 |
$7.26M |
| D0999 |
Unspecified diagnostic procedure, by report |
21,669 |
17,476 |
$3.94M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
18,694 |
16,601 |
$2.63M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,966 |
5,950 |
$975K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
5,000 |
4,481 |
$825K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,463 |
4,456 |
$736K |
| 99441 |
|
3,497 |
3,300 |
$604K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,080 |
3,073 |
$505K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,728 |
2,706 |
$431K |
| 99442 |
|
1,645 |
1,587 |
$284K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
5,774 |
5,712 |
$264K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,162 |
1,099 |
$165K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
980 |
963 |
$146K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
5,882 |
4,235 |
$106K |
| 99381 |
|
444 |
442 |
$70K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
378 |
375 |
$60K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
291 |
280 |
$45K |
| 99384 |
|
254 |
254 |
$44K |
| 1000F |
|
2,333 |
2,139 |
$39K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
256 |
252 |
$37K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
220 |
220 |
$32K |
| 99383 |
|
195 |
195 |
$31K |
| 99443 |
|
163 |
154 |
$28K |
| 91301 |
|
894 |
886 |
$18K |
| 1159F |
|
3,996 |
3,590 |
$14K |
| 99460 |
|
80 |
79 |
$13K |
| 99382 |
|
67 |
66 |
$10K |
| 99385 |
|
65 |
65 |
$10K |
| 1126F |
|
1,271 |
1,161 |
$7K |
| 99462 |
|
39 |
25 |
$5K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
8,747 |
8,723 |
$5K |
| 90461 |
|
5,206 |
5,077 |
$3K |
| 90686 |
|
5,008 |
4,996 |
$2K |
| 1125F |
|
554 |
513 |
$2K |
| 99215 |
Prolong outpt/office vis |
127 |
124 |
$2K |
| 2001F |
|
4,253 |
3,750 |
$2K |
| 2000F |
|
3,087 |
2,797 |
$1K |
| D1120 |
Prophylaxis - child |
2,454 |
2,451 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
206 |
204 |
$1K |
| D1208 |
Topical application of fluoride, excluding varnish |
1,019 |
1,018 |
$925.38 |
| D0150 |
Comprehensive oral evaluation - new or established patient |
1,320 |
1,318 |
$803.32 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,763 |
3,713 |
$691.87 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
416 |
399 |
$639.04 |
| 81002 |
|
347 |
338 |
$633.25 |
| 90633 |
|
2,061 |
2,060 |
$592.12 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
799 |
793 |
$563.77 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,374 |
2,341 |
$552.79 |
| 87807 |
|
411 |
400 |
$536.38 |
| 90696 |
|
925 |
925 |
$474.04 |
| 1220F |
|
876 |
838 |
$447.73 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
125 |
123 |
$435.50 |
| 90698 |
|
1,394 |
1,390 |
$327.24 |
| 90710 |
|
1,743 |
1,742 |
$298.13 |
| 36415 |
Collection of venous blood by venipuncture |
99 |
98 |
$225.49 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
2,072 |
1,985 |
$211.60 |
| 3044F |
|
298 |
266 |
$194.39 |
| 90670 |
|
3,279 |
3,273 |
$173.84 |
| 90681 |
|
1,051 |
1,047 |
$173.84 |
| D1110 |
Prophylaxis - adult |
289 |
289 |
$152.35 |
| 90733 |
|
930 |
930 |
$150.10 |
| 90648 |
|
1,924 |
1,921 |
$148.03 |
| 90700 |
|
836 |
835 |
$148.03 |
| 99000 |
|
507 |
503 |
$148.03 |
| 90651 |
|
938 |
938 |
$148.03 |
| 81003 |
|
2,311 |
2,217 |
$76.40 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
536 |
497 |
$41.95 |
| 90474 |
|
881 |
879 |
$36.45 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
97 |
95 |
$19.14 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
100 |
96 |
$3.27 |
| 1160F |
|
3,845 |
3,457 |
$0.16 |
| 3008F |
|
3,311 |
2,995 |
$0.15 |
| 3078F |
|
2,463 |
2,264 |
$0.10 |
| 3074F |
|
2,874 |
2,627 |
$0.10 |
| 90657 |
|
79 |
79 |
$0.04 |
| D0220 |
Intraoral - periapical first radiographic image |
2,862 |
2,850 |
$0.00 |
| 90473 |
|
180 |
180 |
$0.00 |
| 90715 |
|
995 |
995 |
$0.00 |
| 91300 |
|
449 |
438 |
$0.00 |
| 3077F |
|
97 |
90 |
$0.00 |
| 90734 |
|
64 |
64 |
$0.00 |
| D0274 |
Bitewings - four radiographic images |
906 |
906 |
$0.00 |
| 81025 |
|
963 |
950 |
$0.00 |
| 90756 |
|
54 |
54 |
$0.00 |
| 90649 |
|
287 |
287 |
$0.00 |
| D0330 |
Panoramic radiographic image |
16 |
16 |
$0.00 |
| 87210 |
|
27 |
27 |
$0.00 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
109 |
107 |
$0.00 |
| 90658 |
|
34 |
34 |
$0.00 |
| D2391 |
Resin-based composite - one surface, posterior, primary or permanent |
16 |
12 |
$0.00 |
| 3210F |
|
640 |
563 |
$0.00 |
| 0071A |
|
74 |
74 |
$0.00 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
24 |
24 |
$0.00 |
| 90707 |
|
75 |
75 |
$0.00 |
| 0002A |
|
27 |
27 |
$0.00 |
| D2140 |
|
16 |
13 |
$0.00 |
| 90672 |
|
20 |
20 |
$0.00 |
| D7140 |
Extraction, erupted tooth or exposed root |
199 |
72 |
$0.00 |
| 90723 |
|
1,048 |
1,047 |
$0.00 |
| D0272 |
Bitewings - two radiographic images |
705 |
704 |
$0.00 |
| D1206 |
Topical application of fluoride varnish |
1,419 |
1,418 |
$0.00 |
| D0230 |
Intraoral - periapical each additional radiographic image |
2,439 |
2,320 |
$0.00 |
| 3351F |
|
94 |
94 |
$0.00 |
| D0120 |
Periodic oral evaluation - established patient |
2,338 |
2,336 |
$0.00 |
| 90744 |
|
470 |
470 |
$0.00 |
| 0001A |
|
60 |
60 |
$0.00 |
| D0140 |
Limited oral evaluation - problem focused |
135 |
132 |
$0.00 |
| 4000F |
|
243 |
210 |
$0.00 |
| 90716 |
|
74 |
74 |
$0.00 |
| 91307 |
|
319 |
308 |
$0.00 |
| D0601 |
|
75 |
74 |
$0.00 |
| D1351 |
Sealant - per tooth |
366 |
114 |
$0.00 |
| 3079F |
|
668 |
629 |
$0.00 |
| 82044 |
|
25 |
25 |
$0.00 |
| 3080F |
|
104 |
102 |
$0.00 |
| 91306 |
|
65 |
65 |
$0.00 |
| 3352F |
|
12 |
12 |
$0.00 |
| 90680 |
|
127 |
127 |
$0.00 |
| 3075F |
|
169 |
160 |
$0.00 |
| 0064A |
|
23 |
23 |
$0.00 |
| D0210 |
Intraoral - complete series of radiographic images |
50 |
50 |
$0.00 |
| D2392 |
Resin-based composite - two surfaces, posterior, primary or permanent |
40 |
25 |
$0.00 |
| 0072A |
|
35 |
35 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
31 |
31 |
$0.00 |